Beacon Pointe Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.35M Buy
9,054
+6,474
+251% +$3.31M 0.02% 507
2025
Q4
$1.45M Sell
2,580
-57
-2% -$32.4K 0.01% 709
2025
Q3
$1.36M Sell
2,637
-5,471
-67% -$2.39M 0.01% 655
2025
Q2
$2.54M Buy
8,108
+201
+3% +$60.3K 0.03% 438
2025
Q1
$2.41M Buy
7,907
+299
+4% +$101K 0.03% 430
2024
Q4
$2.53M Buy
7,608
+787
+12% +$267K 0.03% 407
2024
Q3
$2.28M Buy
6,821
+7
+0.1% +$2.66K 0.03% 439
2024
Q2
$2.81M Buy
6,814
+28
+0.4% +$11.1K 0.03% 412
2024
Q1
$2.74M Buy
6,786
+1,272
+23% +$447K 0.03% 426
2023
Q4
$1.69M Buy
5,514
+979
+22% +$264K 0.02% 521
2023
Q3
$1.1M Buy
+4,535
New +$1.16M 0.01% 600
2022
Q2
Sell
-1,385
Closed -$227K 1162
2022
Q1
$227K Buy
1,385
+209
+18% +$34.5K ﹤0.01% 1081
2021
Q4
$256K Hold
1,176
0.01% 790
2021
Q3
$223K Buy
1,176
+46
+4% +$8.39K 0.01% 816
2021
Q2
$200K Sell
1,130
-118
-9% -$20.4K 0.01% 796
2021
Q1
$204K Sell
1,248
-192
-13% -$29.4K 0.01% 505
2020
Q4
$201K Buy
+1,440
New +$181K 0.01% 481

Other funds holding MEDP

Beacon Pointe Advisors's MEDP Position: Q1 2026 in Review

Beacon Pointe Advisors increased its Medpace (MEDP) stake by 251% in Q1 2026, buying an estimated $3.31M and bringing the position to 9,054 shares worth $4.35M. The position accounts for 0.02% of the portfolio, ranked #507.

Beacon Pointe Advisors first reported a position in MEDP in Q4 2020 and has held it in 17 quarters since. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Beacon Pointe Advisors held 9,054 shares of Medpace worth $4.35M as of Q1 2026.
  • Beacon Pointe Advisors bought 6,474 Medpace shares in Q1 2026, an estimated $3.31M.
  • Medpace made up 0.02% of Beacon Pointe Advisors's portfolio in Q1 2026, its #507 holding.
  • Beacon Pointe Advisors first reported a position in Medpace in Q4 2020 and has held it in 17 quarters since.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.